Antibodies

Antibodies

Primary Antibodies

MEK1

BTK

MEK2

AKT1

ERK2

Human

Mouse

Rat

Dog

Monkey

WB

IF

IHC

FC

IP

ELISA

LMNX

Mouse

KO Validated Antibodies

Unconjugated

Biotin

HRP

IgG1

IgG2a

IgG2b

IgG3

Monoclonal

TrueMAB

Druggable Genome

Protein Kinase

ES Cell Differentiation/IPS

Transmembrane

MAPK signaling pathway

Pathways in cancer

Prostate cancer

Fc epsilon RI signaling pathway

GnRH signaling pathway

Toll-like receptor signaling pathway

ErbB signaling pathway

Progesterone-mediated oocyte maturation

Regulation of actin cytoskeleton

Focal adhesion

Endometrial cancer

Non-small cell lung cancer

Oocyte meiosis

Pancreatic cancer

Bladder cancer

Acute myeloid leukemia

Neurotrophin signaling pathway

B cell receptor signaling pathway

Fc gamma R-mediated phagocytosis

Insulin signaling pathway

Colorectal cancer

Glioma

Melanoma

Chronic myeloid leukemia

Gap junction

Renal cell carcinoma

Long-term depression

Long-term potentiation

Natural killer cell mediated cytotoxicity

T cell receptor signaling pathway

Thyroid cancer

VEGF signaling pathway

Vascular smooth muscle contraction

Chemokine signaling pathway

Melanogenesis

Prion diseases

Dorso-ventral axis formation

Amyotrophic lateral sclerosis (ALS)

Cell cycle

Small cell lung cancer

Adherens junction

Calcium signaling pathway

p53 signaling pathway

Axon guidance

Epithelial cell signaling in Helicobacter pylori infection

Adipocytokine signaling pathway

Endocytosis

NOD-like receptor signaling pathway

Primary immunodeficiency

Type II diabetes mellitus

mTOR signaling pathway

RIG-I-like receptor signaling pathway

Wnt signaling pathway

Alzheimer's disease

Apoptosis

Cytokine-cytokine receptor interaction

Jak-STAT signaling pathway

TGF-beta signaling pathway

Tight junction

1